Equillium (EQ) Earnings Date & Reports

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EQ is expected to report earnings to fall 44.78% to -18 cents per share on August 06

Q2'25

Est.

$-0.19

Q1'25

Missed

by $0.05

Q4'24

Beat

by $0.15

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.16

The last earnings report on May 08 showed earnings per share of -33 cents, missing the estimate of -28 cents. With 1.14M shares outstanding, the current market capitalization sits at 12.39M.

View a ticker or compare two or three

Compare